Annual report [Section 13 and 15(d), not S-K Item 405]

Note 17 - Income Taxes - Net Deferred Income Tax Asset (Details)

v3.25.4
Note 17 - Income Taxes - Net Deferred Income Tax Asset (Details) - USD ($)
$ in Thousands
Nov. 30, 2025
Nov. 30, 2024
Net operating loss ("NOL") carryforwards $ 2,002 $ 3,438
Research and development tax credits 430 318
Stock-based compensation 1,230 1,033
Inventory reserve 110 107
Allowance for current expected credit losses 14 70
Personnel costs 949 879
Warranty reserves 35 57
Foreign tax credit carryforwards 9 9
Capital loss carryover 118 115
Unrealized losses 23 14
Deferred revenue 0 21
Lease liability 535 583
Research and experimental capitalization 1,113 802
Business interest limitation 425 325
Subtotal deferred tax assets 6,993 7,771
Valuation allowance (775) (837)
Total deferred tax assets 6,218 6,934
Depreciation and amortization (1,619) (555)
Right of use asset (465) (542)
Total deferred tax liabilities (2,084) (1,097)
Net deferred tax assets (liabilities) $ 4,134 $ 5,837